Musculoskeletal system | |||||
---|---|---|---|---|---|
Musculoskeletal system / Pain and inflammation in musculoskeletal disorders | |||||
aceclofenac | Non-Formulary (or under review) | ||||
aspirin | Non-Formulary (or under review) | ||||
Suppository | |||||
Aspirin (Non-proprietary) | Non-Formulary (or under review) | ||||
celecoxib | Non-Formulary (or under review) | ||||
dexketoprofen | Non-Formulary (or under review) | ||||
diclofenac potassium | Non-Formulary (or under review) | ||||
diclofenac sodium | Specialist Initiated in hospital and continued in Primary Care | ||||
Gastro-resistant tablet | |||||
Diclofenac sodium (Non-proprietary) | Specialist Initiated in hospital and continued in Primary Care | ||||
Eye drops | |||||
Voltarol Ophtha (Thea Pharmaceuticals Ltd) | Non-Formulary (or under review) | ||||
Voltarol Ophtha Multidose (Thea Pharmaceuticals Ltd) | Non-Formulary (or under review) | ||||
etodolac | Non-Formulary (or under review) | ||||
etoricoxib | Non-Formulary (or under review) | ||||
flurbiprofen | Non-Formulary (or under review) | ||||
ibuprofen | Formulary | ||||
indometacin | Formulary | ||||
ketoprofen | Non-Formulary (or under review) | ||||
mefenamic acid | Formulary | ||||
meloxicam | Non-Formulary (or under review) | ||||
nabumetone | Non-Formulary (or under review) | ||||
naproxen | Formulary | ||||
piroxicam | Non-Formulary (or under review) | ||||
sulindac | Non-Formulary (or under review) | ||||
tenoxicam | Non-Formulary (or under review) | ||||
tiaprofenic acid | Non-Formulary (or under review) | ||||
tramadol with dexketoprofen | Non-Formulary (or under review) | ||||
Musculoskeletal system / Local inflammation of joints and soft tissue | |||||
dexamethasone | Specialist Initiated in hospital and continued in Primary Care |
NICE TA229 NICE TA824 NICE TA460 |
|||
Oral solution | |||||
Dexamethasone (Non-proprietary) | Non-Formulary (or under review) | ||||
Dexsol (Rosemont Pharmaceuticals Ltd) | Non-Formulary (or under review) | ||||
hydrocortisone | Specialist Initiated in hospital and continued in Primary Care | ||||
methylprednisolone | Formulary | ||||
prednisolone | Formulary | ||||
triamcinolone acetonide | Formulary | ||||
Suspension for injection | |||||
Adcortyl Intra-articular / Intradermal (Bristol-Myers Squibb Pharmaceuticals Ltd) | Formulary | ||||
Kenalog (Bristol-Myers Squibb Pharmaceuticals Ltd) | Formulary | ||||
triamcinolone hexacetonide | Non-Formulary (or under review) | ||||
Suspension for injection | |||||
Triamcinolone hexacetonide (Non-proprietary) | Non-Formulary (or under review) | ||||
Musculoskeletal system / Soft tissue disorders | |||||
hyaluronidase | Specialist Initiated for Hospital use Only | ||||
Musculoskeletal system / Hyperuricaemia and gout | |||||
allopurinol | Formulary | ||||
colchicine | Formulary | ||||
diclofenac potassium | Non-Formulary (or under review) | ||||
diclofenac sodium | Non-Formulary (or under review) | ||||
Eye drops | |||||
Voltarol Ophtha (Thea Pharmaceuticals Ltd) | Non-Formulary (or under review) | ||||
Voltarol Ophtha Multidose (Thea Pharmaceuticals Ltd) | Non-Formulary (or under review) | ||||
etoricoxib | Non-Formulary (or under review) | ||||
febuxostat | Specialist Initiated in hospital and continued in Primary Care |
NICE TA164 |
|||
indometacin | Specialist Initiated in hospital and continued in Primary Care | ||||
ketoprofen | Non-Formulary (or under review) | ||||
naproxen | Formulary | ||||
sulindac | Non-Formulary (or under review) | ||||
Musculoskeletal system / Arthritis | |||||
abatacept | Specialist Initiated for Hospital use Only |
NICE TA195 NICE TA375 NICE TA715 |
|||
aceclofenac | Non-Formulary (or under review) | ||||
adalimumab | Specialist Initiated for Hospital use Only |
NICE TA187 NICE TA329 NICE TA199 NICE TA195 NICE TA375 NICE TA715 NICE TA383 NICE TA392 NICE TA146 NICE TA460 |
|||
anakinra | Specialist Initiated with ICP for Primary Care |
NICE TA685 |
|||
azathioprine | Specialist Initiated with ICP for Primary Care | ||||
baricitinib | Specialist Initiated for Hospital use Only |
NICE TA466 NICE TA681 NICE TA926 |
|||
celecoxib | Non-Formulary (or under review) | ||||
certolizumab pegol | Specialist Initiated for Hospital use Only |
NICE TA375 NICE TA383 NICE TA415 NICE TA445 NICE TA574 |
|||
chloroquine | Non-Formulary (or under review) | ||||
ciclosporin | Specialist Initiated with ICP for Primary Care |
NICE TA369 |
|||
cyclophosphamide | Specialist Initiated for Hospital use Only | ||||
diclofenac potassium | Non-Formulary (or under review) | ||||
diclofenac sodium | Not Recommended | ||||
Eye drops | |||||
Voltarol Ophtha (Thea Pharmaceuticals Ltd) | Non-Formulary (or under review) | ||||
Voltarol Ophtha Multidose (Thea Pharmaceuticals Ltd) | Non-Formulary (or under review) | ||||
etanercept | Specialist Initiated for Hospital use Only |
NICE TA103 NICE TA195 NICE TA375 NICE TA715 NICE TA199 NICE TA383 |
|||
etodolac | Non-Formulary (or under review) | ||||
etoricoxib | Non-Formulary (or under review) | ||||
flurbiprofen | Non-Formulary (or under review) | ||||
glucosamine | Non-Formulary (or under review) | ||||
golimumab | Specialist Initiated for Hospital use Only |
NICE TA220 NICE TA375 NICE TA225 NICE TA383 NICE TA497 NICE TA329 |
|||
hydroxychloroquine sulfate | Specialist Initiated with ICP for Primary Care | ||||
ibuprofen | Formulary | ||||
indometacin | Non-Formulary (or under review) | ||||
infliximab | Specialist Initiated for Hospital use Only |
NICE TA134 NICE TA195 NICE TA375 NICE TA715 NICE TA199 NICE TA187 NICE TA163 NICE TA329 NICE TA383 |
|||
ketoprofen | Non-Formulary (or under review) | ||||
leflunomide | Specialist Initiated with ICP for Primary Care | ||||
mefenamic acid | Non-Formulary (or under review) | ||||
meloxicam | Non-Formulary (or under review) | ||||
methotrexate | Specialist Initiated with ICP for Primary Care | ||||
nabumetone | Non-Formulary (or under review) | ||||
naproxen | Formulary | ||||
penicillamine | Specialist Initiated with ICP for Primary Care | ||||
piroxicam | Non-Formulary (or under review) | ||||
risankizumab | Specialist Initiated for Hospital use Only |
NICE TA596 NICE TA803 NICE TA888 |
|||
rituximab | Specialist Initiated for Hospital use Only |
NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561 |
|||
sarilumab | Specialist Initiated for Hospital use Only |
NICE TA485 |
|||
sulfasalazine | Specialist Initiated in hospital and continued in Primary Care | ||||
sulindac | Non-Formulary (or under review) | ||||
tenoxicam | Non-Formulary (or under review) | ||||
tiaprofenic acid | Non-Formulary (or under review) | ||||
tocilizumab | Specialist Initiated for Hospital use Only |
NICE TA375 NICE TA247 NICE TA518 NICE TA878 |
|||
tofacitinib | Specialist Initiated for Hospital use Only |
NICE TA480 NICE TA543 NICE TA920 NICE TA547 |
|||
ustekinumab | Specialist Initiated for Hospital use Only |
NICE TA180 NICE TA340 NICE TA456 NICE TA633 |
|||
Musculoskeletal system / Neuromuscular disorders | |||||
riluzole | Specialist Initiated with ICP for Primary Care |
NICE TA20 |
|||
Musculoskeletal system / Myasthenia gravis and Lambert-Eaton myasthenic syndrome | |||||
neostigmine | Specialist Initiated in hospital and continued in Primary Care | ||||
pyridostigmine bromide | Specialist Initiated in hospital and continued in Primary Care | ||||
Musculoskeletal system / Nocturnal leg cramps | |||||
quinine | Formulary | ||||
Musculoskeletal system / Spasticity | |||||
baclofen | Formulary | ||||
cannabis extract | Non-Formulary (or under review) | ||||
dantrolene sodium | Formulary | ||||
diazepam | Formulary | ||||
methocarbamol | Non-Formulary (or under review) | ||||
tizanidine | Specialist Initiated in hospital and continued in Primary Care |